RE: Merck1 Oct 2021 12:49
I was wondering if this might apply to us:
The US pharmaceuticals company said on Friday that it had stopped the phase 3 clinical trial early after an interim analysis showed that 7.3 per cent of patients on the drug had died or been hospitalised, versus 14.1 per cent of those receiving a placebo.